SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001511164-16-000769
Filing Date
2016-04-14
Accepted
2016-04-14 10:47:05
Documents
1
Period of Report
2016-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8kbiotricity41216.htm 8-K 31694
  Complete submission text file 0001511164-16-000769.txt   33274
Mailing Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9
Business Address 75 INTERNATIONAL BLVD., SUITE 300 TORONTO A6 M9W 6L9 (416) 214-3678
BIOTRICITY INC. (Filer) CIK: 0001630113 (see all company filings)

IRS No.: 472548273 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-201719 | Film No.: 161570777
SIC: 3841 Surgical & Medical Instruments & Apparatus